Unknown

Dataset Information

0

MLPA for confirmation of array CGH results and determination of inheritance.


ABSTRACT: BACKGROUND:Array CGH has recently been introduced into our laboratory in place of karyotype analysis for patients with suspected genomic imbalance. Results require confirmation to check sample identity, and analysis of parental samples to determine inheritance and thus assess the clinical significance of the abnormality. Here we describe an MLPA-based strategy for the follow-up of abnormal aCGH results. RESULTS:In the first 17 months of our MLPA-based aCGH follow-up service, 317 different custom MLPA probes for novel aCGH-detected abnormalities were developed for inheritance studies in 164 families. In addition, 110 samples were tested for confirmation of aCGH-detected abnormalities in common syndromic or subtelomeric regions using commercial MLPA kits. Overall, a total of 1215 samples have been tested by MLPA. A total of 72 de novo abnormalities were confirmed. CONCLUSIONS:Confirmation of aCGH-detected abnormalities and inheritance of these abnormalities are essential for accurate diagnosis and interpretation of aCGH results. The development of a new service utilising custom made MLPA probes and commercial MLPA kits for follow-up studies of array CGH results has been found to be efficient and flexible in our laboratory.

SUBMITTER: Hills A 

PROVIDER: S-EPMC2964523 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

MLPA for confirmation of array CGH results and determination of inheritance.

Hills Alison A   Ahn Joo Wook JW   Donaghue Celia C   Thomas Helen H   Mann Kathy K   Ogilvie Caroline Mackie CM  

Molecular cytogenetics 20101013


<h4>Background</h4>Array CGH has recently been introduced into our laboratory in place of karyotype analysis for patients with suspected genomic imbalance. Results require confirmation to check sample identity, and analysis of parental samples to determine inheritance and thus assess the clinical significance of the abnormality. Here we describe an MLPA-based strategy for the follow-up of abnormal aCGH results.<h4>Results</h4>In the first 17 months of our MLPA-based aCGH follow-up service, 317 d  ...[more]

Similar Datasets

| S-EPMC3523000 | biostudies-literature
2008-07-08 | GSE12040 | GEO
| S-EPMC1523216 | biostudies-literature
| S-EPMC3111339 | biostudies-literature
| S-EPMC3726029 | biostudies-literature
| S-EPMC3829466 | biostudies-literature
| S-EPMC1316119 | biostudies-literature
| S-EPMC3776394 | biostudies-literature
| S-EPMC3286622 | biostudies-literature
| S-EPMC549559 | biostudies-literature